scispace - formally typeset
P

Paul R. Caron

Researcher at Vertex Pharmaceuticals

Publications -  35
Citations -  6063

Paul R. Caron is an academic researcher from Vertex Pharmaceuticals. The author has contributed to research in topics: Hepatitis C virus & MAP kinase kinase kinase. The author has an hindex of 19, co-authored 35 publications receiving 5904 citations.

Papers
More filters
Journal ArticleDOI

The structural basis for 14-3-3:phosphopeptide binding specificity.

TL;DR: It is shown that the 14-3-3 dimer binds tightly to single molecules containing tandem repeats of phosphoserine motifs, implicating bidentate association as a signaling mechanism with molecules such as Raf, BAD, and Cbl.
Journal ArticleDOI

X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex

TL;DR: The ternary complex described here represents the three-dimensional structure of a Ser/Thr protein phosphatase and provides a structural basis for understanding calcineurin inhibition by FKBP12-FK506.
Journal ArticleDOI

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

TL;DR: The 2.5 angstrom resolution X-ray crystal structure of the NS3 protease domain complexed with a synthetic NS4A activator peptide is reported, which shows a chymotrypsin-like fold and features a tetrahedrally coordinated metal ion distal to the active site.
Journal ArticleDOI

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

TL;DR: The structure of the HCV NS3 RNA helicase domain complexed with a single-stranded DNA oligonucleotide has been solved to 2.2 A resolution and is a member of a superfamily of helicases, termed superfamily II.
Journal ArticleDOI

Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic Acid

TL;DR: The structure of inosine-5'-monophosphate dehydrogenase in complex with IMP and mycophenolic acid (MPA) has been determined by X-ray diffraction and indicates that MPA inhibits IMPDH by acting as a replacement for the Nicotinamide portion of the nicotinamide adenine dinucleotide cofactor and a catalytic water molecule.